Vaxart, Inc. Profile Avatar - Palmy Investing

Vaxart, Inc.

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet …

Biotechnology
US, South San Francisco [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Vaxart, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Vaxart, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Vaxart, Inc..

End of VXRT's Analysis
CIK: 72444 CUSIP: 92243A200 ISIN: US92243A2006 LEI: - UEI: -
Secondary Listings
VXRT has no secondary listings inside our databases.